Analytical Data
-
Gene name
ZBED2
- Application
-
Alternative Names
MGC10796; ZBED2; ZBED2_HUMAN; Zinc finger BED domain containing Protein 2; Zinc finger BED domain-containing Protein 2; Zinc finger. BED domain containing 2; Zinc finger. BED type containing 2
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BTP6
-
Expression Region
1-218 aa
-
AA Sequence
MMRREDEEEEGTMMKAKGDLEMKEEEEISETGELVGPFVSAMPTPMPHNKGTRFSEAWEYFHLAPARAGHHPNQYATCRLCGRQVSRGPGVNVGTTALWKHLKSMHREELEKSGHGQAGQRQDPRPHGPQLPTGIEGNWGRLLEQVGTMALWASQREKEVLRRERAVEWRERAVEKRERALEEVERAILEMKWKVRAEKEACQREKELPAAVHPFHFV
-
Molecular Weight
51.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZBED2, a member of the BED domain-containing protein family, has garnered significant attention in recent years due to its emerging roles in diverse biological processes, including gene regulation, chromatin remodeling, and cellular development. Initially identified in the context of immunological studies, where it was found to play a critical role in the regulation of certain immune responses, ZBED2 has since been implicated in various malignancies, suggesting a potential link between its function and tumorigenesis. The protein is characterized by the presence of a BED zinc-finger motif, which is thought to facilitate its binding to specific DNA sequences, thus influencing transcriptional activity. Recent advancements in recombinant protein technologies have enabled researchers to produce ZBED2 in vitro, allowing for detailed structural and functional analyses. Understanding the molecular mechanisms by which ZBED2 operates is crucial for elucidating its role in health and disease, as well as for exploring its potential as a therapeutic target. Consequently, ongoing studies focus on the biochemical properties of ZBED2, including its interactions with other proteins and DNA, its expression patterns across different tissues, and its functional consequences in the context of cell biology and pathophysiology. By harnessing recombinant techniques, scientists aim to dissect the complexities of ZBED2 and its contributions to cellular dynamics, making strides toward potential clinical applications in the treatment of diseases where ZBED2 is implicated.
